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Hormones from the fetally derived placenta signal to the mother throughout pregnancy
to ensure optimal fetal growth and prepare the mother for her new role in nurturing
her offspring. Through evolution, placental hormones have under gone remarkable
diversification and species-specific expansions thought to be due to constant
rebalancing of resource allocation between mother and offspring. Genomic imprinting,
an epigenetic process in which parental germlines silence genes in the offspring, is
thought to be the physical embodiment of a second conflicting interest, between the
male and female mammal. Several genes silenced by paternal imprints normally function
to limit the placental endocrine lineages of the mouse placenta. We hypothesized that
paternal imprinting has adapted to overcome the rapid evolution of placental hormone
gene families by directly regulating the lineages that express these hormones rather
than individual hormones. This predicts the existence of genes maternally silenced
in the offspring counteracting the influence of the paternal imprint. Here we report
on the consequences of loss of function of Paternally expressed gene 3 (Peg3), on
placental endocrine lineages. Mutant male placenta displayed a marked loss of the
spongiotrophoblast, a key endocrine lineage of the placenta, and the glycogen cell
lineage alongside reduced stores of placental glycogen and changes in expression
of the normal repertoire of placental hormones. Peg3 is known to transcriptionally
repress placental hormone genes. Peg3 consequently both positively and negatively
regulates placental hormones through two independent and opposing mechanisms.
Female placenta showed moderate response to loss of Peg3 with minor alterations to
the junctional zone lineages and few changes in gene expression. These data highlight
the important fact that female placenta compensate for the loss of Peg3 better than
male placenta. This work lends further support to our novel hypothesis that the parental
genomes are competing over the endocrine function of the mouse placenta and further
suggests that a conflict between males and females begins in utero.
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INTRODUCTION
Eutherian mammals provide nutrients to their young in utero
via the fetally derived placenta enabling prolonged gestation
and the birth of relatively mature offspring central to their
reproductive success (John and Hemberger, 2012). Across
mammalian species there are a wide variety of placental shapes,
sizes, and structures (Carter and Enders, 2004; Capellini et al.,
2011) as well as an extensive diversification of several placental
hormone gene families (Rawn and Cross, 2008). These rapid
changes are thought to reflect the antagonistic yet interdependent
relationship between mother and offspring with higher growth
rates favoring the offspring and counter-adaptation by the
mother to preserve her future reproductive potential (Haig,
1996). A second antagonistic relationship exists between males
and females as a consequence of the inequality of resource
provision to their mutual offspring. Genomic imprinting, an
epigenetic process whereby the paternal and maternal germlines
have switched off certain genes inherited by their offspring
(Surani, 1998), is thought to be a result of these conflicting
interests (Moore and Haig, 1991). However, the continual
evolution of placental hormones, which act to extract resources
from the mother, poses a unique challenge for this theory of
genomic imprinting as rapid evolution would allow genes to
continually escape direct imprinting. We previously reported
on three maternally silenced genes that function to restrain
the development of endocrine lineages of the mouse placenta
(Tunster et al., 2010, 2011, 2014, 2016a,b). This led us to
hypothesize that the paternal genome has overcome the rapid
evolution of placental hormone genes by regulating placental
endocrine lineages rather than specific genes. However, evidence
for maternal silencing of genes to counteract the action of the
paternal genome providing more compelling support for this
hypothesis is lacking.
In mice, seven distinct and identifiable lineages manufacture
placental hormones (Simmons et al., 2007, 2008; Gasperowicz
et al., 2013; Rai and Cross, 2014). The spongiotrophoblast is the
most substantial endocrine lineage in terms of cell number (Coan
et al., 2006), forming the bulk of the junctional zone sandwiched
between the decidua (maternal component of the placenta)
and the labyrinth (fetally derived, nutrient exchange). Paternally
silenced Pleckstrin Homology-Like Domain, Family A, Member
2 (Phlda2) functions to specifically to restrict the expansion of
this lineage with just twofold increased expression reducing the
contribution of the spongiotrophoblast to the mature placenta
by ∼50% (Tunster et al., 2010, 2016a). Conversely, loss-of-
expression of Phlda2 results in a twofold expansion, co-incident
with changes in the expression of spongiotrophoblast-expressed
hormones (Tunster et al., 2016a). Paternally silenced Achaete-
scute complex homolog 2 (Ascl2 aka Mash2) also functions to
restrict the expansion of the spongiotrophoblast (Tunster et al.,
2016b) while paternally silenced Cyclin dependent kinase inhibitor
1c (Cdkn1c) is required for the proper development of this lineage
(Tunster et al., 2011). Cdkn1c support the differentiation of the
second major cell type of the junctional zone, the glycogen
cell lineage, recognized by stores of glycogen that accumulate
as gestation proceeds (Coan et al., 2006). Additionally, there
are a number of other genes paternally silenced by virtue of
their location on the paternally inactivated X chromosome
that regulate cell types within the junctional zone (John and
Hemberger, 2012). The spongiotrophoblast and glycogen cell
lineages expresses members of the placental lactogen gene family
(Prls) (Simmons et al., 2007, 2008). Prls are related to the pituitary
hormone prolactin, and some members of this family play an
important role in driving the maternal adaptations required
for a successful pregnancy (Muller et al., 1999; Bhattacharyya
et al., 2002). There are 22 Prl family members in mice of
which only Prl3d1 (PL-I) and Prl3b1 (PL-II) have formally been
shown to signal via the prolactin receptor (Soares et al., 2007).
In addition to Prls, the spongiotrophoblast lineage expresses
pregnancy specific glycoproteins (Psgs), a 17 member multigene
gene family that contributes to the protection of the semiallotypic
fetus from the maternal immune system and remodels placental
and maternal vasculature (Moore and Dveksler, 2014). The
spongiotrophoblast lineage is important for fetal growth (Tunster
et al., 2010, 2014, 2016a) and the priming of maternal care
during pregnancy (Creeth et al., 2018), which place demands on
maternal resources.
Five distinct trophoblast giant cell (TGC) lineages, recognized
by their giant nuclei, also express Prls (Simmons et al., 2007). The
secondary parietal (P-) TGC are located as a single discontinuous
layer of cells between the maternal decidua, and junctional zone
(Simmons et al., 2007). Overexpression of Ascl2 results 40% fewer
P-TGCs (Tunster et al., 2016b). Sinusoidal TGCs (S-; previously
called trophoblast layer I) are in direct contact with maternal
blood spaces in the labyrinth (Simmons et al., 2007, 2008) and
Cdkn1c is required for their proper development (Tunster et al.,
2011). Spiral artery (SpA-) TGCs line the maternal blood system
in the maternal decidua before entry into the junctional zone,
canal (C-) TGCs line the maternal blood canals entering the
junctional zone and passing through to the labyrinth, and channel
(Ch-) TGCs line the maternal blood spaces located beneath the
decidua where maternal blood leaves the placenta (Gasperowicz
et al., 2013; Rai and Cross, 2014). Alterations in the expression of
Phlda2, Ascl2, and Cdkn1c do not appear to have a major impact
on these lineages. Only one maternally silenced gene, insulin-
like growth factor 2 gene (Igf2), has been well characterized with
respect to the placental endocrine lineages. Gain-in-expression
of Igf2 promotes the expansion of the glycogen cell and P-TGC
lineages with minimal effect on the spongiotrophoblast (Lopez
et al., 1996; Esquiliano et al., 2009).
The function of Phlda2, Ascl2, and Cdkn1c in regulating the
spongiotrophoblast calls attention to this lineage as site of action
for genomic imprinting. However, a paternally expressed gene
with an antagonist function on this lineage has not been reported.
The maternally silenced Paternally expressed gene 3 (Peg3) plays
an important role in both fetal and placental development (Li
et al., 1999; Curley et al., 2004). Altered expression of a number
of spongiotrophoblast-expressed genes in Peg3 knock out (KO)
placenta (Broad et al., 2009; Kim et al., 2013) suggests changes
in the relative contribution of this lineage to the placenta.
However, not all the reported gene changes were consistent
with a simple loss or gain of one or more endocrine lineages.
Transcriptional studies on Peg3 are complicated by its function
Frontiers in Cell and Developmental Biology | www.frontiersin.org 2 September 2018 | Volume 6 | Article 123
fcell-06-00123 September 25, 2018 Time: 19:19 # 3
Tunster et al. Sexually Dimorphic Response to Loss of Peg3
as a zinc finger protein silencing the expression of a number of
placental hormone genes, including several Prls and Psgs (Broad
and Keverne, 2011; Thiaville et al., 2013; Lee et al., 2015) that
are used as markers to identify the seven placental endocrine
lineages. Consequently changes in their expression could indicate
either a change in cell number or changes in expression within a
specific cell type, or potentially both outcomes, highlighting one
of the challenges of using cell lineage markers on heterogeneous
tissues. To overcome this challenge, we employed a combination
of classic histology and gene expression profiling with the
newly developed RNAscope technology to characterize placental
lineages in male and female Peg3 KO placenta. In addition to
finding support for our original hypothesis of parental conflict
over the spongiotrophoblast, we observed differences in both
the placental lineages and gene transcription between male and
female Peg3 KO placenta.
RESULTS
We bred Peg3−/+ (maternal inheritance of targeted allele) Mus
musculus 129 mouse strain males derived from the original line
(Li et al., 1999; Curley et al., 2004) with wild type (WT) 129
females to generate Peg3+/− (paternal inheritance of targeted
allele; KO) and matched Peg3+/+ (WT) fetuses and placenta
at E14.5. There were no differences in fetal weights at E14.5
between WT and Peg3 KO fetuses, and no difference by fetal
sex (Figure 1A). Peg3 KO placenta were 18–20% lighter than
their WT counterparts and wet weights did not differ by fetal sex
(Figure 1B). Fetal:placental ratios were not significantly different
(Figure 1C). Hematoxylin and eosin (H&E) staining of male and
female WT and KO sections suggested subtle differences in the
junctional zone with less cell free space (Figure 1D). The intensity
of Periodic Acid Schiff (PAS) staining, which identifies glycogen
stores (Coan et al., 2006), was similar between the four genotypes
(Figure 1E). A biochemical quantification of placental glycogen
revealed a substantial difference in total glycogen (F3,81 = 5.88,
p = 0.00110; Figure 1F). Male Peg3 KO placenta possessed 43%
less total glycogen (p = 0.0075) and female Peg3 KO placenta
possessed 35% less (p = 0.0389). Glycogen was different as a
proportion of placental weight (F3,81 = 5.88, p = 0.03) but only
between WT and KO male placenta (p = 0.046; Figure 1G).
A reduction in placental glycogen stores can reflect fewer
glycogen cells, as reported in placenta lacking the paternally
expressed Igf2 (Lopez et al., 1996). Alternatively, we have
observed a reduction in placental glycogen when just the
spongiotrophoblast lineage is reduced (Tunster et al., 2016a).
Gross area measurements of midline sections from seven placenta
of each sex/genotype revealed that junctional zone areas were
different between the groups (F3,24 = 5.83, p = 0.00599). Peg3
KO male junctional zone midline area was 34% smaller than
WT male placenta (p = 4.50 × 10−9; Figure 2A). Female
Peg3 KO placenta showed a more modest 19% reduction in
the junctional zone midline area compared to WT female
placenta (p = 5.08 × 10−8; Figure 2A). The increase in
Labyrinth zone:Junctional zone (Lz:Jz) ratio between WT and KO
placenta was not significant (Figure 2B). Quantitative analysis
of junctional zone cell numbers from mid line sections revealed
a difference in the number of spongiotrophoblast (F3,24 = 10.3,
p = 0.000113) and glycogen cells (F3,24 = 7.12, p = 0.0014)
(Figure 2C). Male Peg3 KO placenta possessed 50% fewer
spongiotrophoblast cells (p = 9.06 × 10−4), and female Peg3 KO
placenta showed an attenuated 37% fewer spongiotrophoblast
cells (p = 0.00969). Male Peg3 KO placenta possessed 40% fewer
glycogen cells than WT male placenta (p = 0.00654), and female
Peg3 KO placenta possessed 30% fewer glycogen cells than WT
female controls (p = 0.0384). Male and female Peg3 KO placenta
retained a normal ratio of spongiotrophoblast to glycogen cells
(Figure 2D).
Between WT male and female placenta from Peg3 KO
litters, the majority of markers of the spongiotrophoblast,
TGC lineages, and labyrinth were expressed at similar levels
(Supplementary Figure S1 and Supplementary Table S1).
Trophoblast specific protein alpha [Tpbpa; expressed in glycogen
cells, spongiotrophoblast, SpA-TGCs, C-TGCs, and 50% of
P-TGCs (Hu and Cross, 2011)], Cdkn1c [glycogen cells, P-TGCs
and S-TGCs (Riley et al., 1998; Westbury et al., 2001; Georgiades
et al., 2002; Coan et al., 2006)], Prl2a1 [glycogen cells, SpA-
TGCs and C-TGCs (Simmons et al., 2008)], and exclusive
markers of the glycogen cell lineage Protocadherin 12 (Pcdh12)
(Bouillot et al., 2006), 1,4-alpha-glucan-branching enzyme (Gbe1),
and UDP-glucose pyrophosphorylase 2 (Ugp2) were all expressed
at higher levels in male placenta at E14.5 (Supplementary
Figure S1). This did not translate as increased total placental
glycogen (0.212 mg ± 0.02 vs. 0.201 mg ± 0.02; P = 0.69),
or glycogen per mg of placental weight (3.16 mg/g ± 0.28 vs.
2.94 mg/g ± 0.25; P = 0.57), or a higher glycogen cell number
(1031 ± 95.9 vs. 937 ± 54.6; P = 0.42), in WT male placenta, at
least at E14.5 (Supplementary Tables S1, S2).
Between WT and Peg3 KO male placenta, reduced expression
of markers of the spongiotrophoblast and glycogen cell lineages
was consistent with the loss of both these cells types determined
histologically. Tpbpa was 30–40% lower in Peg3 KO male placenta
relative to WT male controls (Figure 3A). Prl8a8 and Prl8a1,
two markers predominantly or exclusively expressed in the
spongiotrophoblast (Simmons et al., 2008; Figure 3B) and Prl6a1,
an exclusive marker for glycogen cells (Simmons et al., 2008)
were similarly reduced in expression (Figure 3C) while genes
expressed in the labyrinth and pan markers of TGCs were
expressed at WT levels (Figures 3D,E). Not all genes expressed
from the spongiotrophoblast and glycogen cell lineages showed
reduced expression in male Peg3 KO placenta. Strikingly, few
significant reductions in gene changes were apparent in female
Peg3 KO placenta and Psg17 and Psg19, co-expressed with Prl8a8
in spongiotrophoblast (Wynne et al., 2006; Figure 3F), were
expressed at significantly higher levels than WT despite the 37%
loss of this lineage.
Previously, β-galactosidase staining revealed broad expression
of Peg3 in the junctional zone, within cells with large nuclei
lining the region between the junctional zone and maternal
decidua identified as P-TGCs, and some unidentified cells in
the labyrinth (Hiby et al., 2001). We asked whether RNAscope,
an ultrasensitive in situ hybridization amplification technique
(Wang et al., 2012), could provide a more sensitive approach
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FIGURE 1 | Reduction in placental glycogen stores in Peg3 deficient placenta. (A) Wet weights of male and female WT and Peg3 KO fetuses at E14.5. No difference
between WT male (N = 22), and WT female (N = 24), fetal weights, or between WT male and Peg3 KO male (N = 22), or between WT female and Peg3 KO female
(N = 20), fetal weights. Data from 11 litters, litter size between 5 and 10. (B) Wet weights of WT and Peg3 KO placenta at E14.5. No difference in weight between
WT male and WT female placenta. Male and female Peg3 KO placenta weighed 18 and 19% less than sex-matched WT placenta. (C) Fetal:Placental (F:P) ratios at
E14.5. (D) Hematoxylin and eosin staining of male and female WT, and Peg3 KO midline placental sections at E14.5. (E) PAS staining of adjacent male and female
WT and Peg3 KO midline placental sections. (F) Direct biochemical determination of total glycogen (mg) present in male and female WT and Peg3 KO placenta at
E14.5. Male WT placenta contain same total glycogen as female placenta (p = 0.69). Male and female Peg3 KO placenta contain 46 and 33% less total placental
glycogen than sex-matched WT placenta. (G) Glycogen expressed as mg/g placenta. Male and female Peg3 KO placenta contain 35 and 18% less placental
glycogen per gram than sex-matched WT placenta. Scale bars = 1000 µm. Error bars represent SEM. Statistical significance calculated from ANOVA with Bonferroni
correction. Data in Supplementary Table S1.
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FIGURE 2 | Sexually dimorphic loss of spongiotrophoblast and glycogen cells from junctional zone in response to loss of Peg3. (A) Junctional zone (Jz), labyrinth
zone (Lz), and total areas of midline E14.5 placental sections (mm2) from WT, and Peg3 KO male and female placenta. (B) Labyrinth to junctional zone midline area
ratios. (C) Spongiotrophoblast (Spt) and glycogen cell (GlyT) number cell number within midline areas of the junctional zone. (D) Ratio of spongiotrophoblast to
glycogen cell number within the junctional zone. N = 6–7 placenta per genotype, sex matched within litter. Seven independent litters; error bars represent SEM.
Statistical significance calculated from ANOVA with Bonferroni correction. Data in Supplementary Table S2.
for identifying cell types expressing Peg3. This approach allows
the detection of individual target RNAs within intact cells
in alongside multiplex analysis for multiple markers which
can aid lineage identification. We first applied a commercially
available Peg3 RNAscope probe (Supplementary Figure S2A),
to WT paraformaldehyde-fixed sections which revealed a
strong punctuate signal in the nucleus with weaker staining
within the cytoplasm (Supplementary Figures S2B,C). An
identical localization was apparent with a custom designed
Peg3 probe spanning a different region of Peg3 (Supplementary
Figures S2D,E).
We performed triple detection of Peg3 (red) with Prl3b1
(green) to identify spongiotrophoblast cells, P-TGCs, C-TGCs,
and S-TGCs (Simmons et al., 2008), and Pcdh12 (turquoise),
to identify glycogen cells (Bouillot et al., 2006; Figure 4A).
Peg3 was expressed in both Prl3b1+ve, and Pcdh12+ve cells
within the junctional zone (Figure 4B). Peg3 signal within
the Prl3b1+ve spongiotrophoblast cells was stronger, and more
nuclear in comparison to the neighboring Pcdh12+ve glycogen
cells. Some cells with large nuclei located at the periphery of
the junctional zone adjacent to the decidua and strongly positive
for Prl3b1, indicative of P-TGC cells, were weakly positive for
Peg3 signal (Figure 4C and Supplementary Figure S3). A few
cells adjacent to the spiral arteries within the decidua were
positive for Peg3 and Pcdh12 identifying migrated glycogen
cells, not SpA-TGCs (Figure 4D). Peg3 signal was apparent in
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FIGURE 3 | Placental lineage analysis by RT-qPCR reveals differences in the normal repertoire of placental hormone gene expression between male and female
Peg3 KO placenta. (A) RT-qPCR comparison of mature junctional zone markers Tpbpa and Flt1 at E14.5 in male and female Peg3 KO placenta relative to
sex-matched WT placenta. (B) RT-qPCR comparison of markers exclusively or predominantly expressed in the mature spongiotrophoblast lineage. (C) RT-qPCR
comparison of markers exclusively or predominantly expressed in the mature glycogen cell lineage. (D) RT-qPCR comparison of pan-TGC markers. (E) RT-qPCR
comparison of markers of the mature labyrinth, syncytiotrophoblast layers I and II (SynT-I and SynT-II). (F) In situ hybridization of adjacent E14.5 placental sections
with Prl8a8 and Psg17 riboprobes. Scale bars = 100 mm. For the RT-qPCR analysis, N = 4 placenta per genotype and sex, total N = 16 (2 vs. 2 from 2 independent
litters, and 2 vs. 2 of each sex); error bars represent SEM. Statistical significance calculated from ANOVA with Bonferroni correction. ∗P < 0.05. Data in
Supplementary Table S3 and at https://osf.io/jhc83/.
Prl3b1+ve cells with large nuclei lining the maternal vasculature
on entry into the labyrinth (Canal TGCs; Figure 4E) and
exiting via junctional zone (Channel TGCs) (Figure 4F). Peg3
was co-expressed with Prl3b1 in some cells in the labyrinth
indicative of S-TGCs (indicated by arrow Figure 4G). In
addition, there were some cells with small nuclei (indicated by
asterisks) that were Prl3b1−ve/Peg3+ve, and large cells that were
Prl3b1+ve/Peg3−ve (Figure 4G). This reciprocal relationship
between Prl3b1 and Peg3 was consistent with the role of Peg3
transcriptionally repressing Prl3b1 expression (Kim et al., 2013).
In summary, Peg3 was expressed in all endocrine lineages except
the SpA-TGCs.
Triple detection of Peg3, Pcdh12, and Prl3b1 on placental
samples from a single litter further illustrated the differences
between WT and Peg3 KO sections from male and female
placenta identified histologically (Figures 5A–D). The male Peg3
KO placenta (Figure 5B) had relatively fewer Prl3b1+ve cells
compared to the male WT placenta (Figure 5A) and the female
Peg3 KO placenta (Figure 5D) expressed Prl3b1 at higher levels
compared to the matched female WT placenta (Figure 5C).
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FIGURE 4 | Three-plex detection of Peg3, Pcdh12, and Prl3b1 identifies Peg3+ve cells. (A) Low magnification image of whole E14.5 female WT placental section
after in situ amplification of Peg3 (red), Pcdh12 (turquoise), and Prl3b1 (Pl2; green). Nuclei labeled with DAPI (blue). (B) Higher resolution image of region indicated by
open white box labeled Jz in 4A. Peg3 signal localizes to both Prl3b1+ve spongiotrophoblast cells and Pcdh12+ve glycogen cells. Further images in Supplementary
Figure S3. (C) Higher resolution image of region indicated by open white box labeled P-TGC in panel (A). Single RNA molecule detection of Peg3 localized to large
Prl3b1+ve mononuclear cells lining region between decidua and junctional zone indicated by white arrows. (D) Higher resolution image of region indicated by open
white box labeled SpA-TGC in panel (A). Peg3 signal in Prl3b1-ve/Pcdh12+ve cells surrounding maternal spiral artery within decidua indicated by white arrows.
(E) Higher resolution image of region indicated by open white box labeled C-TGC in panel (A). Peg3 signal in Prl3b1+ve cells lining wide channels where maternal
blood enters the labyrinth. (F) Higher resolution image of region indicated by white boxed region labeled Ch-TGC in panel (A). Peg3 signal in Prl3b1+ve cells lining
small channels within the junctional zone. (G) Higher resolution image of region indicated by white boxed region labeled S-TGC in panel (A). Peg3 signal in some
large Prl3b1+ve mononuclear cells located lining the maternal blood sinusoids indicated by white arrows and some Prl3b1-ve cells with small nuclei in labyrinth.
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FIGURE 5 | Three-plex detection of Peg3, Pcdh12, and Prl3b1 expression in WT and Peg3KO male and female E14.5 placenta. Images of whole E14.5 placental
sectional and junctional zone after in situ amplification of Peg3 (red), Pcdh12 (turquoise), and Prl3b1 (Pl2; green). Nuclei labeled with DAPI (blue). All placenta are
from the same litter and treated in an identical manner to generate the images. (A) WT male placenta. (B) Peg3 KO male placenta. (C) WT female placenta. (D) Peg3
KO female placenta. Scale bars between confocal and slide scanner are different because the confocal images at 16 bits and the slide scanner images at 8 bits.
Z = fluorescence intensity value; Y and X = area of the sample.
Although assessed qualitatively, these data highlight the future
potential for this approach in the detailed characterization of
placental lineages.
Both male and female placenta were impacted by loss-
of-function of Peg3 but female placenta presented with
a considerably more subtle phenotype. Sexually dimorphic
expression has been reported for Peg3 (Faisal et al., 2014) but
on the 129 strain background there was no difference in the
expression of Peg3 between E14.5 WT male and female placenta
(Figure 6A). Peg3 expression was fivefold higher in female Peg3
KO placenta compared to male Peg3 KO placenta (Figure 6B).
This was at considerably lower that the normal level of expression
in WT female placenta (Supplementary Table S4) illustrated
by RNAscope analysis of the junctional zone after maternal
transmission of the targeted allele (Figures 6C,D).
DISCUSSION
We previously reported that several paternally silenced imprinted
genes converge on the placental endocrine lineages to limit the
production of placental hormones. This led us to hypothesize
that the male genome adapted to overcome the rapid evolution
of placental hormone gene families by directly regulating the
lineages that express placental hormones rather than individual
hormone genes. Here, we demonstrate that the maternally
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FIGURE 6 | No evidence for substantial relaxation of maternal silencing in
female placenta. (A) RT-qPCR comparison of Peg3 expression between WT
male and WT female placenta at E14.5. (B) RT-qPCR comparison of Peg3
expression between KO male and KO female placenta at E14.5. (C,D) High
resolution image of three-plex analysis of junctional zone of male and female
placenta inheriting the targeted Peg3 allele maternally (silenced). For the
RT-qPCR analysis, N = 4 placenta per genotype (2 vs. 2 from 2 independent
litters); error bars represent SEM. Statistical significance calculated using from
ANOVA with Bonferroni correction. Data in Supplementary Table S4.
silenced Peg3 gene is required for the expansion of the
spongiotrophoblast and glycogen cell lineages consistent with
our original hypothesis (Figure 7), with additional intriguing
complexities.
Peg3 Positively and Negatively
Regulates Placental Hormones
This study applied both classic histological techniques and
a cutting-edge imaging approach to explore the phenotypic
consequences of loss of Peg3 function in the mouse placenta
in more detail. Male Peg3 KO placenta showed a 50% loss of
spongiotrophoblast, a 40% loss of glycogen cells, and a 45%
reduction in placental glycogen alongside 40–60% reduction in
expression of Tpbpa, Flt1, Prl8a8, Prl8a1, and Prl6a1. Not all
genes expressed from the spongiotrophoblast and glycogen cell
lineage were reduced in expression coincident with the loss
of this lineage. This is consistent with the known function
of Peg3 as a transcriptional repressor of placental hormone
genes. The reciprocal relationship between the intensity of
Peg3 and Prl3b1 signal in TGCs (Figure 5) provides further
support for the role of Peg3 as a transcriptional repressor
for Prl3b1 (Kim et al., 2013). Psgs are also targets for Peg3
upregulated in response to loss of function of Peg3 (Broad
and Keverne, 2011) and possess multiple copies of the DNA-
motif for Peg3 (Lee et al., 2015). A key finding from this study
is therefore that Peg3 both positively and negatively regulates
placental hormones through two independent and opposing
mechanisms.
Attenuated Response to Loss of Peg3 in
Female Placenta
Studies in mice are beginning to take into account the possibility
of sexually dimorphic response of the placenta to genetic
and environmental manipulations (Kalisch-Smith et al., 2017).
Mutations involving the Peg3 domain are known to have more
severe effects on males than on females (Kim et al., 2012,
2013; Faisal et al., 2014). In comparison to male placenta,
female Peg3 KO placenta showed a more modest 37% loss
of spongiotrophoblast, 29% loss of glycogen cells, and 33%
reduction in placental glycogen. Aside from Prl8a1 there were no
significant reductions in the expression of genes found be reduced
in male placenta, while Psg17 and Psg19, co-expressed with Prl8a8
in the spongiotrophoblast, were significantly elevated. Prl8a8 was
significantly different between male and female Peg3 KO placenta
but for most other criteria there were no significant differences
between male and female mutants (Supplementary Tables S1–
S4). These findings may be explained by naturally existing
differences between male and female placenta. For example,
Tpbpa was more highly expressed in WT male relative to WT
female placenta and, although not significant with the numbers
used in our study, the area of the Jz was slightly greater in
WT male placenta. The sexually dimorphic response to loss of
Peg3 did not manifest as a significant difference in placental
weight between male and female mutants or in fetal growth
restriction, at least at E14.5. Fetal growth restriction has been
reported at later time points and one study has recorded similar
newborn weights between male and female mutant pups (He
et al., 2016). However, this study examined an imprinting center
mutation on a mixed genetic background and further work is
required.
Minimal Expression From the Maternal
Peg3 Allele
Expression of Peg3 is higher in the placenta of E14.5 male B6/129-
mixed background embryos compared to female (Faisal et al.,
2014) but we did not find a significant difference in Peg3 levels
between male and female 129 placenta. We did find evidence
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FIGURE 7 | Summary of gene expression data in relation to placental lineages. Peg3 is required for the expansion of both the glycogen cell and spongiotrophoblast
lineages. Genes indicated in red are significantly reduced in expression in male Peg3 KO placenta. Genes indicated in green are significantly elevated in female Peg3
KO placenta. ICM, inner cell mass; TE, trophectoderm; TGCs, trophoblast giant cells; ExM, extraembryonic mesoderm; ExE, extraembryonic ectoderm; EPC,
ectoplacental cone; SynT, syncitiotrophoblast.
for expression from the normally silenced maternal allele in
both male and female placenta, with female placenta showing
greater leaky expression. This expression represented <1% of
the WT level, considerably lower than the normally active allele.
While gene expression was analyzed only at E14.5 and we cannot
exclude more significant Peg3 expression from the maternal
allele at earlier stages, it does seem unlikely that such a low
level of expression would be sufficient to even partially rescue
the spongiotrophoblast deficit. Sex-biased outcomes have been
reported in response to mutations of YY1 binding sites in the
Peg3 promoter (He et al., 2017) suggesting another potential
mechanism that may be tempering the phenotype in female
placenta. Whether the mechanism is direct or indirect, these data
highlight the important fact that female placenta compensate for
the loss of Peg3 far better than male placenta.
Relevance to Prenatal Depression in
Humans?
Our observation of a sexually dimorphic response in the placenta
to loss of Peg3 has potentially important implications. We
recently reported reduced expression of the human PEG3 gene
in the placenta from women with either diagnosed depression
in pregnancy or questionnaire determined depressive symptoms
(Janssen et al., 2016). We observed the association in placenta
from male infants but not female infants. We further observed
a reduction in the expression of human placental lactogen,
related to Prls genes in mice, again only in placenta from males.
This current study highlights functional differences between
male and female mouse placenta in response to loss of Peg3.
This sexually dimorphic response might explain why we see
a significant association between placental PEG3 and prenatal
depression in the placenta from boys and not girls in our
human study. In light of these sex-specific phenotypes, it will be
important to further explore both the behavioral phenotype in
mice (McNamara et al., 2017) and gene expression data in human
pregnancies.
SUMMARY
In conclusion, we report that loss of function of the imprinted
Peg3 gene results in the loss of both the spongiotrophoblast and
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glycogen cell lineages. This supports Haig’s original prediction
that imprinted genes will be in conflict over the endocrine
function of the placenta (Haig, 1996) and our hypothesis that
this is achieved through the regulation of placental lineages
that manufacture hormones (John and Hemberger, 2012; John,
2013, 2017). The sexually dimorphic response of the placenta
to loss-of-function of Peg3 and the remarkable fact that Peg3
appears to be required both for the expression and repression of
key placental hormones adds additional layers of complexity to
studying the function of Peg3 both in pregnancy and mammalian
evolution.
MATERIALS AND METHODS
Mouse Strains and Genotyping
Animal studies and breeding were approved by the Universities
of Cardiff Ethical Committee and performed under a United
Kingdom Home Office project license (RJ). All mice were
housed under standard conditions throughout the study
on a 12 h light–dark cycle with lights coming on at
07.00 h with a temperature range of 21◦C ± 2 with
free access to water (tap water), and standard chow. The
Peg3 targeted allele (Li et al., 1999) was crossed into the
129S2/SvHsd (Harlan, 129) strain and Peg3 deficient fetuses were
generated by crossing WT females with heterozygous Peg−/+
(inherited targeted maternal allele; phenotypically wild type)
males.
Weighing Studies, in situ Hybridization,
Histological Analyses, and LacZ staining
Fetal and placental wet weights were taken at the stated
time point after a discernible plug, and normalized as
previously described (Tunster et al., 2010). Genotyping and
sex chromosome typing was obtained from yolk sac DNA
as previously described (John et al., 2001), using primers 5′-
TGCCACTCCCACTGTCCTTT and 5-GCACACAGCCTCTGC
TCTGA for the Peg3 targeted allele and 5′-TGGTCTGGA
CCCAAACGCTGTCCACA and 5′-GGCAGCAGCCATCAC
ATAATCCAGATG for the X and Y chromosome Ube1
gene. Placentas were fixed overnight in phosphate-buffered
4% paraformaldehyde, paraffin-embedded and 6 micron
sections taken through the midline. Riboprobe preparation,
in situ hybridization, H&E and PAS staining, and glycogen
quantifications were performed as previously described (Tunster
et al., 2010).
Calculation of Area and Cell Number
Midline areas were calculated described (Tunster et al., 2010).
Cell counts were performed on the same midline sections, using
the “Cell Counter” plugin for ImageJ. N = 7 for each group (total
N = 28).
Quantitative RNA Analysis
RNA was extracted from whole placenta following careful
removal of membranes and umbilicus. Quantitative PCR
of reverse transcribed RNA (RT-qPCR) was performed and
analyzed as described (Tunster et al., 2010). Data at https://osf.
io/jhc83/.
RNAscope
RNAscope was performed using RNAscope R© Multiplex
Fluorescent Reagent Kit v2 (ACD) on FFPE placenta sections,
following the manufacturer’s protocol with the following
modifications and specifications. After deparaffinization
and hydrogen peroxide incubation, slides were added to
boiling RNAscope R© Target Retrieval for 15 min. Slides
were incubated 15 min at 40◦C in the HybEZ Oven with
Protease Plus. To reduce the autofluorescence background,
washes during the amplification steps with 1× Wash Buffer
were increased from 2 × 2 min at RT to 3 x 5 min at
RT. After amplification steps HRP-C1, HRP-C2, and HRP-
C3 signals were developed. C1 corresponds to Pcdh12
probe (ACD Mm-Pcdh12 489891) and TSA R©Plus Cyanine
3 (Cy3), was assigned for this channel with a fluorophore
concentration of 1:500. C2 corresponds to Prl3b1 probe (ACD
Mm-Prl3b1-C2 423671-C2) and TSA R©Plus fluorescein was
assigned for this channel with a fluorophore concentration
of 1:5000. Peg3 88–994 (original probe Mm-Peg3-C3
492581), custom designed Peg3 3775–4659 (Mm-Peg3-
C3 528201) were in Channel 3, and TSA R©Plus Cyanine
5 (Cy5) was assigned for this channel with a fluorophore
concentration of 1:1000. Under our RT-qPCR conditions
Prl3b1 peaks at cycle 15, Peg3 peaks at cycle 21, and
Pcdh12 peaks at cycle 25 with a 854:48:1 relative ratio
of gene expression (whole placenta) and fluorophores
concentrations were adjusted with respect to mRNA levels
for these genes at E14.5. Slides were counterstained with
DAPI and mounted with Prolong Gold Antifade mounting
medium.
Imaging and Image Analysis
Whole placenta slides were scanned using Zeiss Axio
Scan Z1. Higher resolution images were taken by
the Confocal laser scanning microscope (LSM) 880
with Airyscan. Images were analyzed with ZEN 2
(blue edition) program. Fluorescence intensity 3D
graphs (Figure 5) were generated with the image
processing package Fiji with the interactive 3D service
plot.
Statistical Analyses
Statistical significance (probability values) was determined
using ANOVA with post hoc analyses applying the Bonferroni
correction.
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